548. Baseline characteristics associated with clinical improvement and mortality in hospitalized patients with moderate COVID-19

BACKGROUND: Remdesivir (RDV) has been shown to shorten recovery time and was well tolerated in patients with severe COVID-19. Here we report baseline characteristics associated with clinical improvement at day (d) 14. METHODS: We enrolled hospitalized patients with confirmed SARS-CoV-2 infection, ox...

全面介紹

Na minha lista:
書目詳細資料
發表在:Open Forum Infect Dis
Main Authors: Castagna, Antonella, Hui, David Shu Cheong, Mullane, Kathleen M, Jain, Mamta, Galli, Massimo, Chang, Shan-Chwen, Hyland, Robert H, SenGupta, Devi, Cao, Huyen, Huang, Hailin, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Lübbert, Christoph, Lye, David Chien Boon, Aberg, Judith A, Elorza, Enrique Navas, Tashima, Karen T, McPhail, Mark
格式: Artigo
語言:Inglês
出版: Oxford University Press 2020
主題:
Poster Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7778131/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.742
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍